Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis

Hidden Mastocytosis in Acute Myeloid Leukemia With t(8;21)(q22;q22)

(2013) Ryan C. Johnson et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis

(2013) J. Gotlib et al.   BLOOD

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

(2013) C Ustun et al.   BONE MARROW TRANSPLANTATION

Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies

(2013) E. H. Warren et al.   TISSUE ANTIGENS

Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components

(2012) Sa A. Wang et al.   AMERICAN JOURNAL OF HEMATOLOGY

Significance of Persistent Cytogenetic Abnormalities on Myeloablative Allogeneic Stem Cell Transplantation in First Complete Remission

(2012) Betul Oran et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Mast cell leukemia

(2012) S. Georgin-Lavialle et al.   BLOOD

Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantation

(2012) T Gromke et al.   BONE MARROW TRANSPLANTATION

Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia

(2012) S A Buckley et al.   BONE MARROW TRANSPLANTATION

Death from Mast Cell Leukemia: A Young Patient with Longstanding Cutaneous Mastocytosis Evolving into Fatal Mast Cell Leukemia

(2012) Rattanavalai Chantorn et al.   PEDIATRIC DERMATOLOGY

Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: A case review

(2011) Celalettin Ustun et al.   AMERICAN JOURNAL OF HEMATOLOGY

Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management

(2011) Elihu H. Estey   AMERICAN JOURNAL OF HEMATOLOGY

Tyrosine kinase inhibitors in the treatment of systemic mastocytosis

(2011) Celalettin Ustun et al.   LEUKEMIA RESEARCH

Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia

(2011) Sang Hyuk Park et al.   LEUKEMIA RESEARCH

How I treat patients with advanced systemic mastocytosis

(2010) P. Valent et al.   BLOOD

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission

(2010) D. I. Marks et al.   BLOOD

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns

(2010) V. Gupta et al.   BLOOD

Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis

(2010) K. J. Aichberger et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome

(2010) Brian L. McClune et al.   JOURNAL OF CLINICAL ONCOLOGY

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

(2010) Boglarka Gyurkocza et al.   JOURNAL OF CLINICAL ONCOLOGY

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

(2010) Michel Duval et al.   JOURNAL OF CLINICAL ONCOLOGY

High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V

(2010) Robert Fritsche-Polanz et al.   Molecular Oncology

Allogeneic Stem Cell Transplantation for Adults with Myelodysplastic Syndromes: Importance of Pretransplant Disease Burden

(2009) Erica D. Warlick et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

(2009) K.-H. Lim et al.   BLOOD

Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies

(2009) A. Pardanani et al.   BLOOD

Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology

(2009) W. R. Sperr et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Mechanisms of mast cell signaling in anaphylaxis

(2009) Dean D. Metcalfe et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients

(2009) Luis Escribano et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

(2009) Olle Ringdén et al.   JOURNAL OF CLINICAL ONCOLOGY

Inducible MHC Class II Expression by Mast Cells Supports Effector and Regulatory T Cell Activation

(2009) T. Kambayashi et al.   JOURNAL OF IMMUNOLOGY

Mast cell leukemia: a report of ten cases

(2008) Caterina Giovanna Valentini et al.   ANNALS OF HEMATOLOGY

Phase II Study of Dasatinib in Philadelphia Chromosome-Negative Acute and Chronic Myeloid Diseases, Including Systemic Mastocytosis

(2008) S. Verstovsek et al.   CLINICAL CANCER RESEARCH

Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KITD816V

(2008) Celalettin Ustun et al.   LEUKEMIA RESEARCH